Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer

Clinical trial NCT05349045 · UNKNOWN

Trial details

NCT number: NCT05349045
Sponsor: The First Affiliated Hospital of Zhengzhou University
Status: UNKNOWN
Study type: OBSERVATIONAL

Esophageal Neoplasms

Start date: 2022-05-05
Primary completion: 2024-05-05
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.